Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Canonic Ltd, a unit of Evogene Ltd. (EVGN), announced the pre-launch of its first-generation medical cannabis inflorescence products in Israel. As part of the pre-launch, G-nnovation products will be marketed in Israel to a limited number of licensed patients through Telepharma pharmacy, the company said. Full commercial launch in Israel is anticipated in 2022.


RTTNews | Aug 31, 2021 07:27AM EDT

07:27 Tuesday, August 31, 2021 (RTTNews.com) - Canonic Ltd, a unit of Evogene Ltd. (EVGN), announced the pre-launch of its first-generation medical cannabis inflorescence products in Israel. As part of the pre-launch, G-nnovation products will be marketed in Israel to a limited number of licensed patients through Telepharma pharmacy, the company said. Full commercial launch in Israel is anticipated in 2022.

Ofer Haviv, Chairman of Canonic and CEO & President of Evogene, said: "This milestone was achieved, in part, by using Evogene's platform with its unique computational capabilities in the field of genomics, namely the GeneRator AI tech engine."

Read the original article on RTTNews ( https://www.rttnews.com/3222128/evogene-unit-to-launch-medical-cannabis-products-in-israeli-market-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC